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Abstract
Background: Population-based studies conducted in Latin America have shown a high proportion of
asymptomatic and submicroscopic malarial infections. Considering efforts aiming at regional elimination, it is
important to investigate the role of this asymptomatic reservoir in malaria transmission in peri-urban areas. This
study aimed to estimate the prevalence of Plasmodium spp. and gametocyte burden on symptomatic and
asymptomatic infections in the Brazilian Amazon.
Results: Two cross-sectional household surveys (CS) were conducted including all inhabitants in a peri-urban area
of Manaus, western Amazonas State, Brazil. Malaria parasites were detected by light microscopy (LM) and qPCR.
Sexual stages of Plasmodium spp. were detected by LM and RT-qPCR. A total of 4083 participants were enrolled
during the two surveys. In CS1, the prevalence of Plasmodium vivax infections was 4.3% (86/2010) by qPCR and 1.
6% (32/2010) by LM. Fifty percent (43/86) of P. vivax infected individuals (qPCR) carried P. vivax gametocytes. In CS2,
3.4% (70/2073) of participants had qPCR-detectable P. vivax infections, of which 42.9% (30/70) of infections were
gametocyte positive. The P. vivax parasite density was associated with gametocyte carriage (P < 0.001). Sixty-seven
percent of P. vivax infected individuals and 53.4% of P. vivax gametocyte carriers were asymptomatic.
Conclusions: This study confirms a substantial proportion of asymptomatic and submicroscopic P. vivax infections
in the study area. Most asymptomatic individuals carried gametocytes and presented low asexual parasitemia. This
reservoir actively contributes to malaria transmission in the Brazilian Amazon, underscoring a need to implement
more efficient control and elimination strategies.
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Background
The past two decades have witnessed impressive success
in the reduction of malaria incidence in Latin America,
with the number of confirmed cases decreasing by 31.0%
from 2000 to 2015. Nevertheless, malaria remains a
major public health concern in endemic countries, with
approximately 90 million people being at risk of infec-
tion and an estimated 216 million cases worldwide in
2016 [1]. In 2013 more than 40% of malaria cases in
Latin America occurred in Brazil and, within that coun-
try, more than 99% of all cases were concentrated in the
Amazon region [2]. From 2005 to 2015, malaria inci-
dence in Brazil decreased considerably, as evidenced by
reductions in Annual Parasite Index (79.2%) and total
number of cases (76.5%). This trend was accompanied
by an even more pronounced decline in the proportion
of Plasmodium falciparum, with Plasmodium vivax
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predominance progressively increasing to peak at 88.4% of
total malaria cases in 2015 [3]. Such an impressive reduc-
tion of cases is likely attributable to the governmental pro-
gram focusing on early case detection and treatment [4].
Despite the relative success of control efforts, malaria
transmission still occurs in the Amazon region with major
outbreaks recorded in 1999 and 2005 that may have been
in part due to deforestation, mining activities and new un-
planned rural settlements resulting in environmental
changes favouring malaria transmission [2, 5]. After the
1970s, a large migratory influx from the rural zones to the
peripheries of bigger cities in the Amazon basin resulted
in a precarious and uncontrolled urbanization process, in-
creasing human exposure to anopheline vectors in peri-
urban areas [6, 7]. In Brazilian Amazon, Anopheles
darlingi is the main malaria vector [8, 9].
Latin America is considered a low to moderate mal-
aria transmission region. Recent population based
surveys reported prevalence rates below 6.0% by LM
[10–14]. PCR analyses revealed higher prevalences, ran-
ging between 5.0–17.0% [10–14]. In some studies the
majority of infected individuals did not show malaria-
related symptoms [12, 15]. These results suggest that a
large proportion of infections was submicroscopic and
asymptomatic and would not be detected by routine
diagnostic methods, although asymptomatic infections
are believed to substantially contribute to malaria
transmission. Thus, in this renewed elimination era, it
may seem appropriate to reconsider the role of the
asymptomatic reservoir as a likely source of tran-
smission, especially in low transmission settings. Specif-
ically and actively targeting this reservoir, rather than
relying on passive detection of clinically symptomatic
malaria infections, may be essential to achieve local
elimination.
Most studies examining prevalence of Plasmodium
spp. in the Amazon region were carried out in small
rural or riverine settlements. Additionally, very few stud-
ies assessed the prevalence and density of gametocytes,
the parasite stage responsible for transmission from hu-
man to mosquito vectors. This study aimed to determine
the prevalence of Plasmodium spp. and the gametocyte
burden in symptomatic and asymptomatic infections in
a peri-urban area in the Brazilian Amazon.
Methods
In order to estimate the reservoir of Plasmodium spp.
infected individuals contributing to malaria transmis-
sion, we conducted two large-scale cross-sectional sur-
veys in a peri-urban area of Manaus, located in the
western part of the Amazonas State, Brazil. The pres-
ence of sexual parasite stages in both symptomatic and
asymptomatic infected individuals was also investigated.
Study site
The municipality of Manaus is located on the river Rio
Negro banks, in the northeast of the Amazonas State.
The municipality has an estimated 2,094,301 inhabi-
tants of whom the great majority resides in urban and
peri-urban areas [16]. Intensive migration, as well as
persisting challenges to maintaining an adequate epi-
demiological and entomological surveillance, are con-
tributing to the actively ongoing sustained malaria
transmission in the region. Risk of infection varies be-
tween low and high risk in rural and peri-urban areas.
Highest incidence of malaria cases is commonly ob-
served from May to September, in the dry season when
water levels are declining [17].
The three communities in which this study was con-
ducted, Brasileirinho, Ipiranga and Puraquequara, are
located in the peri-urban area of Manaus (Fig. 1). The
main occupation is in the agricultural sector including
pisciculture. Many people travel to the city daily for
work. There are many places for religious conventions
and leisure activities, where people from the city stay
for the weekend and public holidays. Malaria infections
among these visitors from non-endemic areas of
Manaus are common. Sanitation and garbage collec-
tion services are not available, water is collected from
natural springs or rivers as well as received from a city
service. According to a census performed by a field
team of Fundação de Medicina Tropical Dr. Heitor
Vieira Dourado (FMT-HVD) the population of the
study area (Brasileirinho, Ipiranga and the northern
part of Puraquequara, adjacent to Brasileirinho) was
estimated at around 2400 inhabitants in 2012. Each
community has access to one malaria clinic specifically
conducting malaria diagnosis by microscopy and treat-
ment of cases. Health agents based in this clinic regu-
larly visit homes in order to ensure early detection and
treatment of cases. Sporadically they perform active
detection of febrile cases in the neighbourhood of con-
firmed cases.
Study population and survey method
Two cross-sectional surveys were conducted on a
household-basis, including all inhabitants of all ages
of the study area that were willing to participate in
the study. In case of absence of any family members,
the field team returned to the respective house for a
second time. For each study participant a question-
naire was completed, containing personal information
(age, gender, occupation, pregnancy, history of travel),
information on malaria preventive measures, previous
malaria episodes and current health status. The first
cross-sectional survey (CS1) was conducted from
mid-November 2012 to beginning of January 2013, at
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the beginning of the rainy season, and the second
one (CS2) from the beginning of August 2013 to
mid-September 2013, at the end of the dry season.
Sample collection
Upon participant enrolment, a 300 μl blood sample was
collected from each patient via finger puncture using
Microtainer® tubes containing EDTA and sodium fluor-
ide (Becton Dickinson, NJ, USA). In infants, blood was
obtained by puncture of the heel or toe. Within 1 h of
collection, 50 μl of blood was transferred into a reac-
tion tube containing 250 μl of RNAprotect® (QIAGEN,
Hilden, Germany) in order to preserve RNA for down-
stream analyses [18] and 200 μl of whole blood were
transferred to another reaction tube. Samples were
maintained in cooling boxes until arrival in the labora-
tory, where the 200 μl sample was separated into red
blood cell (RBC) pellet and plasma. All samples were
frozen at -80 °C until further processing. If the col-
lected blood volume was< 250 μl, the actual volume
was recorded.
In order to assess the submicroscopic proportion of
infections, during CS1 two thick blood smears were
prepared for all participants. One slide was analysed at
the local malaria outpost (for diagnostics purposes
only) and the second was analysed by a microscopist at
FMT-HVD for confirmation of species and parasitemia.
In cases of a positive result, participants were treated
by health post staff within 24 h according to the
national guidelines of the Ministry of Health [19].
During CS2 only in the case of symptoms related to
malaria a thick blood smear was prepared for diagnosis
according to the national guidelines. Participants with
positive result received prompt treatment.
Classification of infection status
All participants were tested for P. vivax and P.
falciparum by qPCR (and in CS1 additionally by LM)
to determine positivity of infection. Individuals with
body temperature above 37.5 °C at blood collection or
in the past 48 h were considered as febrile. An asymp-
tomatic infection was defined as the presence of a mal-
arial infection in the absence of fever and any other
malaria related symptoms (chills, sweating, headache,
vomit, abdominal pain) at the moment of sample col-
lection, or anytime during the preceding 48 h. Individ-
uals developing symptoms within 30 days after blood
collection (data obtained from SIVEP-Malaria database,
Information System for Epidemiological Surveillance of
Malaria of the Brazilian Ministry of Health) were also
considered symptomatic and therefore excluded from
the asymptomatic group.
Detection of Plasmodium spp. parasites by light
microscopy
Thick blood smears were Giemsa-stained according to
World Health Organization guidelines [20]. Numbers
of asexual blood stage parasites and gametocytes were
determined per 200 leukocytes and parasites per μl
were calculated using an assumed density of 6000 leu-
kocytes per μl [21]. For quality control purposes, all
slides with positive results and 10% of all negative slides
were read by a second microscopist. In case of a posi-
tive/negative discrepancy, or when parasitemias were in
disagreement by more than 25.0%, the slides were re-
read by a third microscopist and only the two most
similar results were used for calculation of final parasite
density. All PCR positive samples were examined at
least twice by LM.
Fig. 1 Study area and distribution of malaria infected individuals (red: P. falciparum, blue: P. vivax) enrolled at cross-sectional surveys, detected by qPCR
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DNA and RNA extraction
Pelleted RBCs obtained from 200 μl blood were resus-
pended in PBS and genomic DNA was extracted using
FavorPrepTM 96-well Genomic DNA Kit (Favorgen,
Ping-Tung, Taiwan) according to the manufacturer’s in-
structions. DNA was eluted with 2 × 100 μl of elution
buffer and stored at -20 °C until analysed by PCR. If the
amount of whole blood available for DNA extraction
was ≤ 100 μl, the DNA volume was vacuum concen-
trated (Concentrator 5301, Eppendorf, Hamburg,
Germany) according to the volume originally collected.
RNA from whole blood stored in RNAprotect was ex-
tracted by means of the RNeasy® Plus 96 kit (Qiagen,
Hilden, Germany) as described elsewhere [18].
Detection of Plasmodium spp. by qPCR and detection of
gametocyte-specific transcripts by RT-qPCR
All DNA samples were subjected to QMAL Taqman
qPCR to detect Plasmodium spp. by targeting a con-
served region of the 18S rRNA gene [18]. QMAL-
positive samples were further analysed by Taqman qPCR
assays detecting species-specific sequences of 18S
rRNA gene of P. falciparum and P. vivax, as previously
described [18, 22]. For detection of P. falciparum a
modified reverse primer was used (Additional file 1:
Table S1) [23]. For quantification of 18S rRNA gene
copy numbers, in each experiment three dilutions of
plasmids containing the respective region targeted were
included in triplicates (102, 104 and 106 copies/μl). All
samples positive for P. vivax and/or P. falciparum were
included in RT-qPCR assays detecting the respective
transcripts of p25 gene (pvs25 in P. vivax and pfs25 in P.
falciparum), which is specifically expressed in gameto-
cytes. For quantification of pvs25 and pfs25 transcripts,
standard plasmids containing the region targeted by the
RT-qPCR were included in each run. All qPCR and RT-
qPCR assays were ran in the 7500 Fast Real-Time PCR
System (Applied Biosystems, California, USA). Primer
and probe sequences, composition of reaction mixes,
PCR profiles and the detection limit for each assay are
listed in Additional file 1: Table S1, Additional file 2:
Table S2 and Additional file 3: Table S3.
Statistical analyses
Questionnaire data were imported into databases using
Cardiff TeleForm version 10.4.1 (Cardiff Software). Indi-
vidual databases were combined in Microsoft Access
2010. Statistical analyses were performed with STATA®
13 (StataCorp LP, College Station, TX, USA). Differences
in participant characteristics, parasite prevalence and
carriage of gametocyte between the two surveys were
analysed by Chi-square (χ2) test (replaced by Fisher’s
exact test if necessary). Univariable logistic regression
was used to determine risk factors for P. vivax infection
and gametocyte positivity. The crude odds ratios (OR)
with their respective 95% confidence intervals (95% CI)
were determined considering P. vivax infection and
gametocyte carriage as the dependent variables. Logistic
regression was used for the multivariable analyses and
the adjusted ORs (AOR) with 95% CI were also calcu-
lated. All variables associated with the outcomes at a sig-
nificance level of P < 0.20 in the univariable analysis
were included in the multivariable analysis. Median
comparisons for copy number between surveys and be-
tween symptomatic and asymptomatic individuals were
made using Mann-Whitney test. Differences were con-
sidered statistically significant for P < 0.05. Association
between P. vivax parasite density and P. vivax gameto-
cyte density was analysed by linear regression.
Results
Study population
A total of 4083 participants were included in the two
surveys: 1047 people were surveyed only once during
the beginning of the rainy season in 2012 (CS1), 1110
only during the 2013 dry season (CS2) and 963 at both
time points (Table 1). Overall, 2138 participants were
male (52.4%), 507 were aged under 5 years (12.4%), 710
were 5–11 years-old (17.4%), 502 were 12–17 years-old
(12.3%), 1974 were 18–59 years-old (48.3%) and 388
were 60 years-old or older (9.5%), with no significant dif-
ferences regarding age (χ2 = 2.815, df = 4, P = 0.589) or
gender (χ2 = 0.119, df = 1, P = 0.731) between surveys.
Besides pre-school (15.0%) and school children (24.4%),
15.4% of participants were adults working in agriculture/
fishing, 14.3% worked in an office or pursued high edu-
cation studies, while 15.6% were house wives and 5.0%
retired (Table 1). Ten percent were engaged in other
professions or unemployed. The majority of participants
had lived in the village for longer than two months
(CS1: 93.8%, CS2 97.8%, χ2 = 40.359, df = 1, P < 0.0001)
and few had travelled outside the village in the month
prior to the survey (CS1: 9.4%, CS2: 9.0%, χ2 = 0.196,
df = 1, P = 0.658) (Table 1).
The majority of participants lived in households that
had benefited from vector control activities. In CS1
73.7% (1482/2010) of participants were using LLINs
(long-lasting insecticide-treated nets) and/or lived in a
house that was treated with indoor spraying of residual
insecticides (IRS) in the preceding six months, in CS2 it
was 54.5% (1131/2073) of participants (χ2 = 162.812, df
= 1, P < 0.0001). In CS1, 50.1% (1008/2010) used LLINs,
56.7% (1140/2010) lived in an IRS treated house, and
33.1% (666/2010) of participants had benefited from
both interventions. As LLIN distributions and IRS spray-
ing campaigns were conducted in the months prior to
CS1, the proportion of people that reported benefitting
from either intervention was significantly higher in CS1
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Table 1 Characteristics of study participants
Variable CS1 CS2 χ2 P-value
n % n %
Total 2010 100.0 2073 100.0
Demographic
Community
Ipiranga 439 21.8 487 23.5 34.507 < 0.0001
Brasileirinho 1185 59.0 1049 50.6
Puraquequara 386 19.2 537 25.9
Gender
Male 1058 52.6 1080 52.1 0.119 0.731
Female 952 47.4 993 47.9
Age group
< 5 yrs 256 12.7 251 12.1 2.815 0.589
≥ 5–11 yrs 361 18.0 349 16.8
12–17 yrs 253 12.6 249 12.0
18–59 yrs 957 47.7 1017 49.1
≥ 60 yrs 181 9.0 207 10.0
Occupation
Office worker and higher education student 318 15.8 296 14.3 45.221 < 0.0001
Agriculture/fishing 349 17.4 277 13.4
Housewife 289 14.4 346 16.7
Retired 106 5.3 97 4.7
School children 481 23.9 484 23.4
Infants and preschool children 312 15.5 300 14.5
Unemployed/ other 154 7.7 269 13.0
More than 2 months in the area
Yes 1866 93.8 2017 97.8 40.359 < 0.0001
No 124 6.2 46 2.2
Recent travel (last month)
Yes 188 9.4 186 9.0 0.196 0.658
No 1814 90.6 1883 91.0
Malaria control
Use of a bednet
No use 1002 49.9 1297 62.6 317.571 < 0.0001
< 1 yr 940 46.8 487 23.5
1–2 yrs 68 3.4 289 13.9
IRS past 6 months
Yes 1140 56.7 759 36.6 165.854 < 0.0001
No 869 43.3 1313 63.3
Fly screen
Yes 376 18.8 408 19.7 0.565 0.452
No 1627 81.2 1663 80.3
Almeida et al. Parasites & Vectors  (2018) 11:194 Page 5 of 13
than for CS2 (Table 1, P < 0.0001). In addition, consider-
ing data from both CS1 and CS2, 19.2% (784/4083) of
participants lived in households with screened windows.
Plasmodium spp. prevalence
In CS1, 86 of 2010 (4.3%) participants were infected
with P. vivax as determined by qPCR. Prevalence by
qPCR was thus 2.7-fold higher than prevalence by
LM (1.6%) (Table 2). Fifty percent (43/86) of all P.
vivax infected individuals (qPCR) carried P. vivax ga-
metocytes when detected by RT-qPCR, whereas
56.3% (18/32) of P. vivax infections detected by LM
were positive for gametocytes. A modestly lower
prevalence of P. vivax infections was observed in
CS2 with 3.4% (70/2,073) of participants having
qPCR-detectable infections, although this difference
between surveys did not reach statistical significance,
irrespective of considering all participants (Table 2,
χ2 = 2.259, df = 1, P = 0.133) or only those that were
surveyed twice (CS1: 45/963, 4.7% vs CS2: 33/963,
3.4%, χ2 = 1.924, df = 1, P = 0.165). A comparable
number of P. vivax infections were gametocyte
positive in both surveys (50.0% vs 42.9%, χ2 = 0.791,
df = 1, P = 0.374). Total P. vivax parasitemia was com-
parable in both surveys (median gene copy number/
μl 21.8 vs 35.0, Mann-Whitney test: U = 2643.5, n1 =
86, n2 = 70, P = 0.192) but pvs25 transcript numbers
were significantly higher in gametocyte positive sam-
ples in CS2 compared to CS1 (median 11.4 vs 44.6
transcripts/μl, Mann-Whitney test: U = 417.5, n1 =
43, = n2 = 30, P = 0.011). Overall, P. falciparum in-
fections were rare (Table 2): In CS1 only 15 mono P.
falciparum infections were detected by qPCR (0.8%);
in CS2 a single mixed P. falciparum/P. vivax infection was
detected (0.05%, χ2 = 12.739, df = 1, P = 0.0004). Among P.
falciparum positive samples in CS1, 81.8% (9/11)
showed presence of gametocytes by light microscopy
and 93.3% (14/15) by qPCR. In CS2, the only P. fal-
ciparum positive sample was also positive for gameto-
cytes by qRT-PCR.
Table 1 Characteristics of study participants (Continued)
Variable CS1 CS2 χ2 P-value
n % n %
Malaria morbidity
Previous episodes
0 587 29.3 606 29.3
1–3 656 32.8 614 29.6 6.479 0.091
4–10 455 22.7 487 23.5
> 10 303 15.1 359 17.3
Episode in past two weeks
Yes 24 1.2 21 1.0 0.307 0.580
No 1986 98.8 2052 99.0
Current symptoms
Fevera 108 5.4 84 4.1 3.974 0.046
Symptoms other than feverb 76 3.8 16 0.8 42.857 < 0.0001
Abbreviations: CS1, cross-sectional survey 1; CS2, cross-sectional survey 2
a> 37.5 °C at visit or past 48 h
bExcluding individuals with other symptoms and fever
Table 2 Prevalence of infection by P. vivax (Pv total), P. vivax gametocytes (Pv gam), P. falciparum (Pf total) and P. falciparum
gametocytes (Pf gam) as determined by light microscopy and PCR. Microscopy data available only for cross-sectional survey (CS)
1, overall prevalence by PCR determined as 18S rDNA copies/μl by qPCR, gametocyte prevalence by PCR determined by RT-qPCR
(pvs25 transcripts/μl)
CS1 Microscopy (n = 2010) CS1 PCR (n = 2010) CS2 PCR (n = 2073)
n % Median paras./μl IQR n % Median cop./transcr./μl IQR n % Median cop./transcr./μl IQR
Pv total 32 1.8 195.0 60.0–555.0 86 4.3 21.8 6.0–246.4 70a 3.4 35.0 12.3–273.0
Pv gam 18b 1.0 60.0 30.0–60.0 43 2.1 11.4 3.8–85.1 30a 1.4 44.6 13.5–175.1
Pf total 11 0.5 240.0 90.0–600.0 15 0.8 151.8 8.1–681.3 1a 0.05 5.1 –
Pf gam 9b 0.4 150.0 60.0–270.0 14 0.7 434.9 40.0–1272.8 1a 0.05 154.8 –
aIncluding one Pf/Pf mixed infection
bOne slide was negative for asexual blood stages
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Morbidity and univariate risk-factors for P. vivax infection
Combining the results of both CS1 and CS2, prevalence
of P. vivax was about twice as high in Brasileirinho and
Puraquequara (4.3%) than in Ipiranga (2.1%, χ2 = 10.198,
df = 2, P = 0.006) (Additional file 4: Table S4). The pro-
portion of infected individuals was higher among male
study participants (4.8%) than among female participants
(2.7%) and male participants had a significantly higher
risk for infection (OR: 1.81, 95% CI: 1.28–2.58, χ2 =
12.137, df = 1, P = 0.0005). Adults (≥ 18 years, preva-
lence 4.8%) had a higher risk for infection than
children (2.4%) (OR: 2.02, 95% CI: 1.40–2.97, χ2 =
15.369, df = 1, P = 0.0001). The risk for infection was
significantly higher for workers from the agriculture
sector than for office workers and individuals pursu-
ing higher education (OR: 1.81, 95% CI: 1.03–3.17, χ2
= 28.208, df = 1, P = 0.0001).
Prevalence amongst new residents (4.1%) was only
slightly higher than that for individuals that lived in
the study area for more than two months (3.8%, OR:
1.08, 95% CI: 0.42–2.32, χ2 = 0.035, df = 1, P = 0.852).
Individuals with recent travel history showed a lower
prevalence (2.4%) than individuals that did not leave
the study area (4.0%, OR: 0.60, 95% CI: 0.30–1.18, χ2
= 2.271, df = 1, P = 0.132. Plasmodium vivax preva-
lence was higher amongst individuals using LLINs
(4.7%, OR: 1.53, 95% CI: 1.11–2.11, χ2 = 6.796, df = 1,
P = 0.009) and for participants living in IRS-treated
houses (4.6%, OR: 1.51, 95% CI: 1.09–2.09, χ2 = 6.361,
df = 1, P = 0.012) as compared to persons not using
either intervention measure (3.1%). The proportion of
P. vivax infected individuals was lower, but not significant,
if the individual´s home had screened windows (3.2%),
compared to those individuals living in houses with un-
screened windows (4.0%, OR: 0.80, 95% CI: 0.52–1.24, χ2
= 1.006, df = 1, P = 0.316).
Study participants that had not experienced malaria
episodes during their lifetime showed a lower risk for
infection (prevalence 0.8%) than participants with one
or more previous malaria infections (5.1%, OR: 7.04,
95% CI: 3.59–15.75, χ2 = 43.030, df = 1, P < 0.0001). Fur-
thermore, P. vivax prevalence was higher in individuals
that experienced a recent malaria episode (7.0%) than
in individuals with no recent episode (3.8%, OR: 1.94,
95% CI: 0.77–4.88, Fisher’s exact test P = 0.195). Indi-
viduals presenting fever the day of the visit or during
the past 48 h had a significantly increased risk for in-
fection by P. vivax (prevalence 14.1%, OR: 4.77, 95%
CI: 3.06–7.43, χ2 = 57.510, df = 1, P < 0.0001). Individ-
uals with symptoms other than fever (up to 48 h before
visit) had a moderately increased, albeit not-significant,
prevalence (5.4%) as compared to asymptomatic indi-
viduals (3.63%, OR: 1.55, 95% CI: 0.48–34.83, Fisher’s
exact test: P = 0.386) (Additional file 4: Table S4).
Table 3 Multivariate predictors of infection by P. vivax
n % AOR 95% CI P-value
Gender
Male 2138 4.8 2.22 1.41–3.51 0.001
Female 1945 2.7 – –
Occupation
Office worker and higher education student 614 3.3 – –
Agriculture/fishing 626 5.8 1.68 0.96–2.95 0.009
Housewife 635 4.3 2.46 1.28–4.71
Infants and preschool children 612 2.0 1.47 0.63–3.40
School children 965 2.5 0.95 0.51–1.78
Retired 203 3.9 1.12 0.48–2.63
Unemployed/other 423 6.9 2.13 1.16–3.89
Number of previous episodes
0 1193 0.8 –
1–3 1270 3.9 5.25 2.37–11.65 < 0.001
4–10 942 5.9 7.75 3.46–17.36
> 10 662 6.2 7.01 2.95–16.64
Fevera
Yes 192 14.1 4.66 2.88–7.53 < 0.001
No 3891 3.3 – – -
a> 37.5 °C at visit or past 48 h
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Multivariate risk factors for P. vivax infection
After adjusting for potential confounders (community,
vector control activities and age) gender, occupation,
history of malaria and fever remained as independent
predictors for P. vivax infection. In the multivariate ana-
lysis male individuals were at higher risk for infection by
P. vivax than female individuals (Table 3, AOR: 2.22,
95% CI: 1.41–3.51, P = 0.001). Individuals that reported
to have had one or more previous malaria episodes in
their lives were at much higher risk for P. vivax infection
than individuals that had no previous infection (Table 3,
P < 0.001). Another factor strongly associated with P.
vivax infection was fever (during visit or during the past
48 h) (AOR: 4.66, 95% CI: 2.88–7.53, P < 0.001).
Carriage of P. vivax gametocytes
Overall, about half of all P. vivax infected individuals (73/
156, 46.8%) were positive for gametocytes, detected by
RT-qPCR. Both in the univariate (OR: 2.73, 95% CI: 1.85–
4.05, P < 0.0001) and in the multivariate (AOR: 2.67, 95%
CI: 1.90–3.77, P < 0.0001) analyses the only risk factor as-
sociated with detectable carriage of gametocytes was P.
vivax parasite density. We modelled the probability for
carriage of gametocytes (defined as positivity by RT-qPCR
in a 50 μl blood sample) depending on P. vivax density
using a generalised additive model (Fig. 2a). For low para-
site densities (< 10 18S rDNA copies/μl) the probability
was below 30.0% and increased only slightly. At 100 cop-
ies/μl the probability to carry gametocytes was 50.0% and
increased dramatically reaching a probability of 90.0% at
10,000 copies/μl. Gametocyte density (measured as pvs25
transcripts/μl) also increased with P. vivax density (r2 =
0.496, P < 0.0001) (Fig. 2b).
Both prevalence of P. vivax blood-stages and preva-
lence of P. vivax gametocytes increased with age. The
density of P. vivax blood-stages and pvs25 transcripts
was highest in children younger than 12 years (Fig. 3).
Asymptomatic and submicroscopic infections
Overall, 82.7% (129/156) of all people infected with P.
vivax did not report a concurrent febrile illness and 75.0%
(117/156) of infected individuals did not report fever or
any other symptoms (the day of visit or up to 48 h before)
nor did they report with symptoms to a malaria clinic
during the 30 days before visit. Of these asymptomatic
individuals, 11.1% (13/117) developed symptoms within
30 days after the visit. Thus, 67.3% (104/156) of all P.
vivax infected individuals were and remained asymptom-
atic. There was no significant difference between CS1
(56/86) and CS2 (48/70) (χ2 = 0.2073, df = 1, P = 0.649).
Similarly, 76.7% (56/73) of P. vivax gametocyte positive
individuals were afebrile and 64.4% (47/73) were asymp-
tomatic. 53.4% (39/73) of individuals carrying P. vivax
gametocytes were asymptomatic (at visit and past 30 days)
and did not develop any symptoms within 30 days after
the visit (Fig. 4). Febrile (at visit or past 48 h) P. vivax
infections were of significantly higher density (median
copy numbers/μl: 463.8, IQR: 13.5–5030.4) than afebrile
infections (20.8, IQR: 6.7–113.5, Mann-Whitney test: U =
985.5, n1 = 27, n2 = 129, P = 0.0004). Individuals showing
any malaria-related symptoms up to the past 48 h also
exhibited a significantly higher parasite density (median
copy numbers: 282.6, IQR: 6.9–4452.6) as compared
to asymptomatic infections (20.3, IQR: 6.7–103.4,
P = 0.0007, Fig. 5). In CS1, 65.6% (42/64) of asymp-
tomatic and 54.5% (12/22) of symptomatic P. vivax
infections were submicroscopic (χ2 = 0.860, df = 1,
P = 0.354) (Fig. 6).
Of the 16 P. falciparum infections (including 1 mixed
infection), 12 (75.0 %) were asymptomatic (at visit or up
Fig. 2 Relation between P. vivax parasitaemia and gametocyte carriage and gametocyte density. A generalized additive model was used to
describe gametocyte positivity (a). Plasmodium vivax parasitaemia was determined by qPCR (18S rDNA copies/μl) and gametocyte density by
RT-qPCR (pvs25 transcripts/μl) (b)
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to 48 h before). Of the 15 individuals carrying P. falcip-
arum gametocytes, 11 (73.3%) were asymptomatic. None
of the P. falciparum infected individuals developed
symptoms within 30 days after the visit (Fig. 4). Four
(35.7%) asymptomatic P. falciparum infections in CS1
were submicroscopic, while all symptomatic infections
were detectable by LM (Fig. 6).
Discussion
The two cross-sectional surveys conducted in the per-
iphery of Manaus confirmed the low prevalence of mal-
arial infections in the area. This is in accordance with
the significant successes recently achieved in Brazil re-
garding malaria control, whereby from 2000 to 2011 the
number of cases has been more than halved [24]. This
success has been attributed to classical intervention
measures including early recognition and treatment of
malaria cases and a high coverage of LLIN distribution
[2]. The prevalence observed in CS2 (August-September
2013) was slightly lower than that of CS1 (November-
December 2012). Although in the Amazon region mal-
aria transmission usually peaks during the dry period
from June to September, year-to-year fluctuations occur
due to variation in climatic conditions [6, 17, 25].
Most infections were caused by P. vivax; only 14.9%
(CS1) and 1.4 % (CS2), respectively, were caused by
P. falciparum, in accordance with a decreasing trend
in P. falciparum cases in Brazil since 1989 [25]. In
the municipality of Manaus, for instance, P. falcip-
arum infections dropped from 40.8% in 1986 to 6.5%
in 2003 [7]. In addition to intervention strategies
focusing on early diagnosis and treatment, the intro-
duction of artemisinin-based combination therapy in
2006 further enhanced this trend [2]. Early treatment
is generally more efficient against P. falciparum than
P. vivax [26], as the appearance of mature
Fig. 3 Prevalence of P. vivax blood-stages and P. vivax gametocytes and parasite densities in different age groups. Geometric mean and 95%
confidence interval are shown Plasmodium vivax blood-stage (Pv) density was determined by qPCR (18S rDNA copies/μl) and gametocyte
(Pv gam) density by RT-qPCR (pvs25 transcripts/μl)
Fig. 4 Proportion of asymptomatic infections. Fever and other symptoms as reported on day of visit or up to 48 h before. Symptoms more than
2 days before or after visit according to Information System for Epidemiological Surveillance of Malaria (SIVEP-Malária). Abbreviations: Pv total, all P.
vivax blood stages; Pv gam, P. vivax gametocytes; Pf total, all P. falciparum blood stages; Pf gam, P. falciparum gametocytes
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gametocytes occurs later during infection. Addition-
ally, the need to ensure radical treatment of P. vivax
often jeopardizes the adequate management of this
species because of compliance issues. As a conse-
quence, in many co-endemic settings successful con-
trol has resulted in a shift from P. falciparum to P.
vivax being the most prevalent parasite [27, 28].
Multivariate analysis revealed gender and occupation
as key factors associated with infection by P. vivax, with
male individuals being at higher risk as compared to
female. This difference can possibly be explained by
different occupation and leisure related behaviour. For
instance, one third of adult men were working in the
agricultural sector, which was associated with an ele-
vated risk for infection (although not significant). One
fifth of adult men had stated to be unemployed or pur-
sue other not classified occupations. That group was sig-
nificantly associated with infection. Among the different
occupation groups housewives were at highest risk for P.
vivax infection, probably because many houses in the
study area include an outside area where activities such
as laundry or gardening are performed. Our observations
are in agreement with a previously published study
conducted in a farming settlement in the South of the
Amazon State where an increased risk of infection for
individuals working in agriculture or housekeeping oc-
curred [10]. In the univariate model age also represented
a risk factor for P. vivax infections, showing an elevated
risk for adolescents and adults, although this is likely as-
sociated with behaviour rather than age. The strongest
predictor for P. vivax infection was fever. However, one
has to keep in mind that in areas with such high propor-
tion of asymptomatically infected individuals, in some
cases the fever potentially might be caused by other con-
current (often unrelated) infectious diseases.
We were not able to find a protective effect for LLINs
or IRS. Univariate analyses showed instead that both
intervention measures were associated with a higher risk
for infection by P. vivax. This can probably be explained
by increased attention and control measures by both
health post agents and inhabitants in known transmis-
sion hotspots. Whether LLINs and IRS can reduce mal-
aria transmission in South America is not fully clear yet,
as the main vector in the region, An. darlingi, is to a
large extent exophilic, with its main peak of activity
occurring at nightfall [29]. In addition, many of the
detected P. vivax infections might result from reacti-
vated hypnozoites rather than from recent mosquito
bites. According to a study carried out in Papua New
Guinea, relapses may be the cause of about 80% of P.
vivax episodes [30]. A recent study from the Brazilian
Amazon also suggests a significant contribution of re-
lapses in this region [14].
Amongst individuals positive for P. vivax, we identified
P. vivax blood-stage parasite density as the only risk fac-
tor for carrying gametocytes. Other studies also identi-
fied (asexual) blood stage density as a major predictor
for carriage of gametocytes [31, 32]. Furthermore, we
observed a weak correlation between total parasitaemia
and gametocyte density. In P. vivax, gametocytes appear
early in infection and their production continues
Fig. 5 Parasite densities of P. vivax infected asymptomatic (n = 38)
and symptomatic (n = 118) individuals as determined by qPCR (18S
rDNA copies/μl). Box plot showing median and interquartile range.
Malaria-related symptoms at the day of visit or up to 48 h before
visit were considered
Fig. 6 Proportion of submicroscopic infections by P. vivax (Pv total),
P. vivax gametocytes (Pv gam), P. falciparum (Pf total) and P.
falciparum gametocytes (Pf gam) among individuals with or without
symptoms (at sample collection or up to 48 h before)
Almeida et al. Parasites & Vectors  (2018) 11:194 Page 10 of 13
throughout the infection, thus explaining increased risk
for gametocyte carriage and increasing gametocyte dens-
ities with increasing P. vivax parasitaemia [33].
About half of all P. vivax positive individuals were
positive for gametocytes. Other reports show higher
rates of gametocyte carriers; however, these symptomatic
individuals had high parasite densities that correlated
with better detection of gametocytes [10, 34, 35]. A
study that used large blood volumes for RNA extraction
and subsequent RNA extraction achieved a high sensitiv-
ity of detecting both asexual and sexual stages [10],
while in our study only 50 μl of patient blood was used
for RNA extraction. In addition, the proportion of gam-
etocyte positive individuals depends on the sensitivity of
the assay detecting parasitaemia of blood-stage parasites
- the more sensitive, the lower the parasite densities be-
ing detected, and therefore the probability of being posi-
tive for (detectable) gametocytes [32]. Gametocyte count
by LM was performed on 200 leukocytes in the samples
from this study, which may have underestimated the
prevalence of gametocytes in infected individuals. The
sensitivity of gametocyte detection could be improved
counting more microscopic fields.
Up to three quarters of all P. vivax infected individ-
uals appeared to be free of symptoms on the day of
blood sampling. The majority of them also remained
free of symptoms for the following 30 days, as previ-
ously reported [10, 15]. We were able to demonstrate a
high proportion of asymptomatic infections in a low
transmission setting, as previously described in the
Americas [15, 36].
Among the individuals positive for P. vivax gameto-
cytes, the proportion of asymptomatic individuals was
smaller. This can be explained by the lower chance to
detect gametocytes in low blood-stage parasite densities,
such as observed in asymptomatic individuals. Despite
having lower parasitemia, and therefore lower gametocy-
temia, asymptomatic infections had been shown to be
able to infect mosquitoes [37] and hence, might be an
important reservoir, especially for seasonal outbreaks
[26]. A study in southern Amazon State estimated that
54.4% of all parasite biomass belonged to asymptomatic
infected individuals, accounting for 56.6% of all infec-
tions [14]. As asymptomatic carriers do not seek health-
care facilities, they do not receive treatment and
therefore might remain infective over long periods. Fur-
thermore, a large proportion of asymptomatic infections
is submicroscopic and would therefore by standard diag-
nostic methods remain undetected. Overall, more than
half of P. vivax infections (62.8%) were submicroscopic,
as opposed to only 26.7 % of P. falciparum infections.
Two recent reviews reported similar proportions of sub-
patent (69.5% [38] and 67.0% [39]) P. vivax infections
and substantially lower proportions of subpatent P.
falciparum infections in various studies from different
continents. In Brazil only LM positive infections are
treated, thus the malaria subpatent infections remain
untreated.
This work is the first large-scale survey assessing the
infectious reservoir, and therefore the malaria transmis-
sion potential, with molecular methods in the peri-urban
area of Manaus. We identified a large proportion of
asymptomatic and submicroscopic malaria infections
implicating that these might play an important role in
malaria transmission in the study area. These infections
are not only a burden to the local population, but also
responsible for infections in (malaria-naïve) visitors [6].
Classical intervention measures are not effective against
subpatent infections and new control measures will
therefore be needed to achieve elimination. Although
PCR is not suitable for routine diagnostics, as it is ex-
pensive and technically challenging, molecular data as
those arising from our study can provide important in-
formation on the infectious reservoir, for instance for
mathematical models [39]. A clearer understanding of
the dynamics of the infectious reservoir over time is
needed and longitudinal studies will be critical in order
to assess the duration of asymptomatic infections and
their likely role in sustaining transmission in the area.
Conclusions
This study shows a substantial proportion of asymptom-
atic and submicroscopic P. vivax infections in the studied
area. The majority of gametocyte carriers did not present
symptoms, thus indicating that asymptomatic infections
might significantly contribute to malaria transmission in
this region. Therefore, efficient control and malaria elim-
ination tools need to include approaches also targeting the
asymptomatic reservoir. Longitudinal studies are needed
in these locations to analyze the incidence of malaria in-
fection and the risk factors for P. vivax gametocyte
carriage.
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